B
12.66
0.13 (1.04%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 看跌 |
| Medical Devices (全球的) | 混合的 | 看跌 | |
| 股票 | Beta Bionics, Inc. | 看涨 | - |
AIStockmoo 评分
0.2
| 分析师共识 | 5.0 |
| 内部交易活动 | -1.5 |
| 价格波动 | 0.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.20 |
|
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 6.51% |
| 机构持股比例 | 98.41% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 28.00 (Truist Securities, 121.17%) | 购买 |
| 中 | 26.00 (105.37%) | |
| 低 | 17.00 (Baird, 34.28%) | 保留 |
| 平均值 | 23.67 (86.97%) | |
| 总计 | 2 购买, 1 保留 | |
| 平均价格@调整类型 | 19.96 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Goldman Sachs | 01 Oct 2025 | 26.00 (105.37%) | 购买 | 20.21 |
| Truist Securities | 22 Sep 2025 | 28.00 (121.17%) | 购买 | 22.90 |
| 30 Jul 2025 | 21.00 (65.88%) | 购买 | 16.76 | |
| Baird | 30 Jul 2025 | 17.00 (34.28%) | 保留 | 16.76 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合